Use of growth hormone-releasing peptide 6 (GHRP-6) for the prevention of multiple organ failure
Summary
Demonstrated that GHRP-6 administration prevented multiple organ failure in a liver ischemia-reperfusion injury model. The cytoprotective effects were mediated through anti-inflammatory and antioxidant mechanisms independent of growth hormone release.
Key Findings
- GHRP-6 prevented multiple organ failure following hepatic ischemia-reperfusion injury
- Cytoprotective effects were independent of GH secretion
- Reduced oxidative stress markers and pro-inflammatory cytokine levels across multiple organs
Access Full Text
Read the complete published study from the original source.
View on Publisher SiteRelated Monographs
Related Studies
View all →Pharmacokinetic study of growth hormone-releasing peptide 6 (GHRP-6) in rats
Cabrales A, Gil J, Fernández E, et al.
European Journal of Pharmaceutical Sciences
Comprehensive pharmacokinetic characterization of GHRP-6 in rats following intravenous and subcutaneous administration. Established bioavailability parameters, distribution, and elimination kinetics essential for dosing protocol development.
- Characterized absorption, distribution, and elimination kinetics of GHRP-6
- Established subcutaneous bioavailability parameters for dosing optimization
Regulation of growth hormone secretion by growth hormone-releasing peptide-6 (GHRP-6)
Micic D, Popovic V, Doknic M, et al.
Journal of Pediatric Endocrinology
Early clinical characterization of GHRP-6 as a potent growth hormone secretagogue in humans. Demonstrated that GHRP-6 stimulates GH release through a mechanism distinct from GHRH, and that combined administration produces synergistic GH responses.
- GHRP-6 potently stimulated GH release in human subjects
- Mechanism of action distinct from growth hormone-releasing hormone (GHRH)